Article
CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population.
Psychiatry and clinical neurosciences - 1 Aug 2001
Woo S I, Kim J W, Seo H G, Park C H, Han S H, Kim S H, Kim K W, Jhoo J H, Woo J I
Abstract excerpt
CYP2D6*4 polymorphism is reported to be associated with Parkinson's disease (PD) and to have protective role against Alzheimer's disease (AD). Such findings are not extensively studied in the Oriental population, especially Koreans. The effects of CYP2D6*4 polymorphism on AD and PD were investigated by polymerase chain reaction-restriction fragment length polymorphism in Korean subjects. Heterozygous mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
